About the Authors
- Xavier Duval
-
Affiliations Inserm CIC 007, APHP, Hôpital Bichat, Paris, France, Inserm U738, Paris, France, Université Paris Diderot, Paris 7, UFR de Médecine, site Bichat, Paris, France
- Sylvie van der Werf
-
Affiliations Institut Pasteur, Centre National de Référence des virus influenzae (Région-Nord), Unité de Génétique Moléculaire des Virus à ARN, Paris, France, CNRS URA3015, Paris, France, Université Paris Diderot, Paris 7, UFR Sciences du Vivant, Paris, France
- Thierry Blanchon
-
Affiliations Inserm UPMC UMR-S 707, Faculté de médecine Pierre et Marie Curie, Paris, France, Université Pierre et Marie Curie, Paris 6, UFR de Médecine, U707, Paris, France
- Anne Mosnier
-
Affiliation Réseau des Groupes Régionaux d'Observation de la Grippe (GROG), Coordination nationale, Paris, France
- Maude Bouscambert-Duchamp
-
Affiliations Hospices Civils de Lyon, Centre National de Référence des virus influenzae (Région-Sud), GHE, Bron, France, Université Lyon 1, VirPatH, CNRS FRE 3011, Lyon, France
- Annick Tibi
-
Affiliations APHP- Agence Générale des Equipements et Produits de Santé, Unité Essais Cliniques, Paris, France, Université Paris Descartes, Paris 5, Faculté de Pharmacie, Paris, France
- Vincent Enouf
-
Affiliation Institut Pasteur, Centre National de Référence des virus influenzae (Région-Nord), Unité de Génétique Moléculaire des Virus à ARN, Paris, France
- Cécile Charlois-Ou
-
Affiliation Université Paris Diderot, Paris 7, UFR de Médecine, site Bichat, Laboratoire de Recherche en Pathologie Infectieuse, Paris, France
- Corine Vincent
-
Affiliations Inserm U738, Paris, France, Université Paris Diderot, Paris 7, UFR de Médecine, site Bichat, Paris, France, APHP, Hôpital Bichat, Unité de Biostatistiques, Paris, France
- Laurent Andreoletti
-
Affiliations Hôpital Robert Debré, Unité de Virologie médicale, Reims, France, Unité de Virologie Médicale et Moléculaire Faculté de Médecine Université Champagne-Ardenne IFR53/EA-4303, Reims, France
- Florence Tubach
-
Affiliations Inserm U738, Paris, France, Université Paris Diderot, Paris 7, UFR de Médecine, site Bichat, Paris, France, APHP Hôpital Bichat, Département d'Epidémiologie, Biostatistiques et Recherche Clinique, Paris, France
- Bruno Lina
-
Affiliations Hospices Civils de Lyon, Centre National de Référence des virus influenzae (Région-Sud), GHE, Bron, France, Université Lyon 1, VirPatH, CNRS FRE 3011, Lyon, France
- France Mentré
-
Affiliations Inserm U738, Paris, France, Université Paris Diderot, Paris 7, UFR de Médecine, site Bichat, Paris, France, APHP, Hôpital Bichat, Unité de Biostatistiques, Paris, France
- Catherine Leport
-
* E-mail: catherine.leport@univ-paris-diderot.fr
Affiliations Université Paris Diderot, Paris 7, UFR de Médecine, site Bichat, Laboratoire de Recherche en Pathologie Infectieuse, Paris, France, APHP, Unité de Coordination des Risques Epidémiques et Biologiques, Paris, France
- and the Bivir Study Group
-
¶Membership of the BIVIR Study Group is provided in the Acknowledgments.
Competing Interests
XD has had a conference invitation from GSK and lecture fees from Roche and Gilead. AM has membership in the ministry of health advisory board on influenza; involvement in some epidemiological studies partially or fully granted by Roche and GSK, and travel grants from Roche for participation in scientific meetings. SVDW has had a conference invitation from GSK; research grant from GSK on unrelated subject; joined patent from institution with GSK on unrelated subject; travel grants for meetings from GSK; contribution to clinical trial financed by Roche; member of the advisory committee on influenza of the French ministry of health; is a member of ESWI; is a member of the scientific committee of the GEIG; and is vice-president of the GROG network. FM received fees from Roche, preclinical pharmacokinetic department, for a course on MONOLIX in December 2008. BL has had paid consultancy and board membership (Roche, GSK, Novartis, BioCryst, MedImmune), has had research grants from Roche and Sanofi-Pasteur, and had received travel grants and honoraria for speaking or participation at meetings (Roche, Sanofi-Pasteur).
Author Contributions
ICMJE criteria for authorship read and met: SvdW TB AM AT VE CCO CV LA FT BL FM CL. Agree with the manuscript's results and conclusions: XD SvdW TB AM MBD AT VE CCO CV LA FT BL FM CL. Designed the experiments/the study: XD SvdW TB AM VE CCO LA BL FM CL. Analyzed the data: XD SvdW TB AM CV LA FT BL FM CL. Collected data/did experiments for the study: XD SvdW TB AM MBD VE CCO FT BL FM CL. Enrolled patients: CCO. Wrote the first draft of the paper: XD SvdW TB BL FM CL. Contributed to the writing of the paper: XD SvdW TB AM MBD AT VE CCO LA FT BL FM CL. Enrolled investigators and took part in the epidemiological surveillance which gave the go-ahead to the study: AM. Responsible for data monitoring: FT. Obtained funding: FM CL.